Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC

NCT04791176 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Radiotherapy
Lenvatinib

Interventions

RADIATION: concurrent lenvatinib and Radiotherapy, followed lenvatinib maintenance

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences